Hematológica

  • Home
  • Hematológica

Hematológica Diagnóstico, tratamiento y seguimiento de enfermedades hematológicas benignas y malignas.

04/03/2025

📢 La Agrupación Mexicana para el Estudio de la Hematología (AMEH A.C.) tiene el honor de presentar el LXVI Congreso Nacional de Hematología 2025 🩸🔬

📅 Del 15 al 18 de octubre de 2025
📍 Puerto Vallarta, México

Durante cuatro días, podrás disfrutar de un programa académico de alto nivel con:
🎤 Conferencias magistrales con expertos internacionales
📚 Simposios y cursos para actualizarte en la práctica clínica
☕ Cafés con expertos para el intercambio cercano de ideas
📊 Presentaciones de investigación con los últimos avances en el campo

💡 Además, tendrás acceso a actividades diseñadas para mantenerte a la vanguardia en hematología, en un ambiente que fomenta la colaboración y el aprendizaje.

📢 Más información, próximamente: 👉 https://www.amehac.org/congresos/lxvi-congreso-nacional-de-hematologia-2025/

15/09/2024

🩸🩸Evolution of the use of Therapeutic Fibrinogen Concentrate in the Massive Bleeding Guidelines🩸🩸

🩸En pacientes con politraumatismo con hemorragia grave, se recomienda la administración de fibrinógeno en función de criterios clínicos y antes de los resultados de las pruebas de laboratorio.
🩸🩸Después de este primer enfoque, las directrices recomiendan el manejo de la coagulación dirigido a objetivos basado en los resultados de las pruebas viscoelásticas y, en su ausencia, se recomiendan las pruebas de laboratorio clásicas.🩸

https://openanesthesiajournal.com/VOLUME/18/ELOCATOR/e25896458339158/

14/09/2024

𝗩𝗗𝗝 𝗿𝗲𝗰𝗼𝗺𝗯𝗶𝗻𝗮𝘁𝗶𝗼𝗻 is a process involving the cutting and rejoining of the loci encoding T-cell and B-cell receptors. These loci are highly polymorphic and contain multiple variable (V), diversity (D), and joining (J) regions, flanked by recombination signal sequences (RSS). Each developing T and B cell rearranges the locus to generate a unique transcript containing one V, one D, and one J region, a process known as VDJ recombination. The RAG1–RAG2 protein complex begins this process by cutting at RSS sites. More about this NEJM Illustrated Glossary term in comments.

14/09/2024

Curso a distancia "Actualización en Hematología SAH"
Disponible a partir del 16/9/2024
www.sahcampus.org.ar

13/05/2024

An unusual presentation of systemic mastocytosis in a myelolipoma

A 51-year-old man with a history of anaphylactic reaction to hornet venom presented with abdominal pain, melena, and bowel habit changes. No skin lesions or hepatosplenomegaly were identified. Positron emission and computed tomography revealed a retroperitoneal fat-containing mass in the left lower abdominal quadrant, measuring 5.7 cm in its greatest dimension (panel A-B, arrow). A needle-core biopsy of the mass showed hematopoietic elements (panel C: hematoxylin and eosin stain, 50× objective) with a small aggregate of elongated cells associated with eosinophils (panel D, 50× objective). The cells were positive for mast cell tryptase, CD117, and CD25 (panels E-F, 20× and 50× objectives, respectively). The findings were compatible with myelolipoma and an abnormal mast cell aggregate suspicious for mastocytosis. Complete blood cell count was normal. Subsequent bone marrow biopsy showed abnormal CD25+ mast cell aggregates, comprising 5% of the cellularity. There was no evidence of dysplasia or increased blasts. Cytogenetics showed a normal male karyotype 46,XY[19]. Myeloid next-generation sequencing was negative for pathogenic variants in myelodysplastic syndrome–associated genes. The tryptase level was 23.6 ng/mL (reference value,

13/05/2024

In a 28-year-old woman with postpartum immune thrombotic thrombocytopenic purpura, plasma exchange was unsuccessful. Near death while receiving vasopressors, she was treated with recombinant ADAMTS13, and the disease abated. Read the Brief Report: https://nej.md/4b77CsZ

13/05/2024

Amastigota de Leishmania.

13/05/2024

Read here results of the prospective, phase II, open-label, parallel-group, multicenter clinical trial to compare autologous-allogeneic tandem stem cell transplantation (alloTSCT) to autologous tandem transplantation (autoTSCT) followed by 2 years of maintenance therapy with thalidomide in patients with multiple myeloma.
https://haematologica.org/article/view/haematol.2023.282920

13/05/2024
12/05/2024

¿Te interesa saber más sobre las coagulopatías y sus implicaciones en diferentes contextos?

📕El documento «Consultas frecuentes en coagulopatías» ofrece respuestas a preguntas comunes sobre , coagulopatías durante el , coagulopatías en y consultas relacionadas con la reversión de la .

👉Disponible en: https://seth.es/consultas-frecuentes-en-coagulopatias/

Address


Alerts

Be the first to know and let us send you an email when Hematológica posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Hematológica:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram